SCHEMBL4178475

SCHEMBL4178475

CCOc1ccccc1Oc1ccc(C#N)c(Cl)c1

nearest known ligand 0.68

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
AR P10275 11/20 0.68
SLC22A12 Q96S37 5/20 0.49
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
KCNH2 Q12809 1/20 0.44
PGR P06401 1/20 0.44
GAA P10253 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4179840 0.85 AR (0.69) ARSLC22A12HTR2ASLC6A4KCNH2
SCHEMBL4178023 0.84 AR (0.74) ARSLC22A12PGRGAAPOLB
SCHEMBL4181484 0.83 AR (0.68) ARSLC22A12HTR2ASLC6A4KCNH2
SCHEMBL4200879 0.83 AR (0.53) ARSLC22A12HTR2ASLC6A4KCNH2
SCHEMBL13890551 0.82 AR (0.75) ARSLC22A12KCNH2GAAPOLB
SCHEMBL753907 0.82 AR (0.75) ARSLC22A12KCNH2PGRGAA
SCHEMBL4188133 0.82 AR (0.62) ARSLC22A12HTR2ASLC6A4KCNH2
SCHEMBL4175953 0.81 AR (1.00) ARSLC22A12PGRGAAPOLB
SCHEMBL4172657 0.81 AR (0.68) ARSLC22A12HTR2ASLC6A4KCNH2
SCHEMBL4188116 0.81 AR (0.68) ARSLC22A12HTR2ASLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105349-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2009-04-23 US claimed
EP-1781280-A2 ANDROGEN MODULATORS Warner-Lambert Company LLC (US) 2007-05-09 EP claimed
WO-2006018723-A2 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2006-02-23 WO claimed
US-20090105349-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2009-04-23 US disclosed
US-20090105349-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2009-04-23 US disclosed
US-20090105349-A1 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2009-04-23 US disclosed
EP-1781280-A2 ANDROGEN MODULATORS Warner-Lambert Company LLC (US) 2007-05-09 EP disclosed
WO-2006018723-A2 ANDROGEN MODULATORS WARNER-LAMBERT COMPANY LLC (US) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105349-A1 ANDROGEN MODULATORS AR, NR5A1, SHBG AR 1/4885SLC22A12 3958/4885HTR2A 562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.